FREMONT, Calif. — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Chief Operating Officer, Chris Williams, will resign his position effective September 27, 2024, to accept a CEO position at another company. Cytek has chosen not to replace the COO position, opting instead to restructure the organization to […]
Appointment of leading technology innovator supports continued commercial development and R&D expansion Previously Senior Executive at Illumina, Co-Founder and former CEO of Helixis and Luxtera Cambridge, UK: Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Dr. Alex Dickinson to its Board of Directors as a […]
The clarification is that it is the nomination committee of Nanologica AB that has presented the proposal to elect Alexandra Blomberg Montgomery to the board of directors of Nanologica AB. The nomination committee, consisting of Carl-Johan Spak (Flerie Invest AB), Lennart Francke (Swedbank Robur funds), and Kalle Olby (Vega Bianca AB), has in connection with […]
Qkine is delighted to announce the appointment of Rob Nixon to its leadership team as Commercial Director and Paul Grafham as Chief Financial Officer. With years of experience working with fast-growing biotechs and life science reagent suppliers, these appointments will support the execution of the company’s growth strategies and expansion of its commercial operations globally. […]
CytoTronics, Inc., a pioneer of semiconductor-based platforms for discovery in cell biology, today announced a $13.5 million seed extension financing and the appointment of Sameer Rohatgi of LYFE Capital to their Board of Directors. The Series Seed 2 round was led by new investor, LYFE Capital, and existing investor Anzu Partners. New investors including Legend Star, RIT Venture Fund (Rochester […]
Accomplished R&D Leader and CRISPR Tools Expert Joins VedaBio to Drive Platform Expansion and Industrialization SAN DIEGO — VedaBio, a biotechnology company leading a paradigm shift in molecular detection, today announced the appointment of G. Brett Robb, Ph.D., as Senior Scientific Director and Head of CRISPR Science. With over 16 years of experience in life […]
Succeeds Dr. Stephen Schwartz Following 14-Year Tenure BURLINGTON, Mass. — Azenta, Inc. (Nasdaq: AZTA) (“Azenta” or “the Company”), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024, succeeding Dr. Stephen Schwartz, who is retiring following a distinguished tenure. Dr. Schwartz will remain as an advisor to Azenta to ensure a smooth […]
Christine Munz appointed as CEO Wilhelm Plüster completes term in office as planned Hamburg – The Supervisory Board of Eppendorf SE has appointed Dr. Christine Munz as the new CEO of the Eppendorf Group. On October 1, 2024, she will succeed Dr. Wilhelm Plüster who will now take on other strategically relevant responsibilities in the […]
Promotions expand C-suite leadership as company transitions to commercial operation and commences development of large-scale single cell product pipeline. SAN DIEGO and CAMBRIDGE, England — CS Genetics, a privately held genomics technology company, today announced the promotion of Jay Harger, PhD, to the position of Chief Operating Officer, and of Mike Stubbington, PhD, to the position of Chief Scientific Officer. In […]
BC Platforms, a global leader in real world data, healthcare data management, and analytics, today announces the appointment of a new Chairperson of the Board. Jan Berger is a seasoned executive with deep experience at the intersection of healthcare, life sciences, and information technology. Under her leadership BC Platforms continues to drive growth in the global markets […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
